Question: is yervoy a checkpoint inhibitor?
Answer: Checkpoint inhibitor drugs that target CTLA-4 Ipilimumab (Yervoy) is a monoclonal antibody that attaches to CTLA-4 and stops it from working. This can boost the body's immune response against cancer cells. This drug is used to treat melanoma of the skin and continues to be tested for other cancers.